Table 7.
Unadjusted incidence, prevalence, and survival of all renal replacement therapy populations, combined.
| Country | Reference | Source | Year(s) of survey | Ages surveyed (years) | Incidence (pmp) | Prevalence (pmp) | Survival (%) |
|---|---|---|---|---|---|---|---|
| Europe | |||||||
| Denmark | ERA-EDTA [18] | Registry | 2012 | All | 115.8a | 872.3 | 1 yr: 85.3c |
| France | ERA-EDTA [18] | Registry | 2012 | All | 142.2a | 1138.7 | — |
| Germany | Frei et al. [31] | Registry | 2006 | All | 213 | 1114 | — |
| Greece | ERA-EDTA [18] | Registry | 2012 | All | 185.6a | 1135.7 | 1 yr: 85.3c |
| Italy | ERA-EDTA [18] | Registry | 2010 | All | — | 905.9 | 1 yr: 85.3c |
| Portugal | ERA-EDTA [18] | Registry | 2012 | All | 207.3a | 1670.2 | — |
| Russian Federation | ERA-EDTA [18], USRDS [25] | Registry | 2012 | All | 48.1 | 213.9 | — |
| Spain | ERA-EDTA [18] | Registry | 2012 | All | 93.0–138.6a | 1092.1 | 1 yr: 85.3c |
| Sweden | ERA-EDTA [18] | Registry | 2012 | All | 101.8a | 933.0 | 1 yr: 85.3c |
| Netherlands | ERA-EDTA [18] | Registry | 2012 | All | 112.9a | 923.4 | 1 yr: 85.3c |
| United Kingdom | UKRR [19] | Registry | 2012 | ≥20 | 100.0a | 867.1 | 1 yr: 87.3a |
| Asia | |||||||
| China | Zuo et al. [30] | Survey | 2008 | All | 36.1 | — | — |
| Hong Kong | Ho et al. [28] | Registry | 1995–2011 | All | 157 | 1152.5 | — |
| India | Modi and Jha [29] | Survey | 2008 | All | 160b | — | — |
| Japan | USRDS [25] | Registry | 2011 | All | 295 | — | — |
| Republic of Korea | Korean ESRD Registry [35] | Registry | 2013 | All | 234.0 | 1446.4 | — |
| Turkey | ERA-EDTA [18] | Registry | 2012 | All | 138.6 | 815.6 | — |
| Oceania | |||||||
| Australia | ANZDATA [26] | Registry | 2012 | All | 112 | 919 | — |
| The Americas | |||||||
| Brazil | Rosa-Diez [27] | Registry | 2010 | All | 173.7 | 708.7 | — |
| Canada | CORR [24] | Registry | 2012 | All | 155.7 | 1,182.7 | — |
| Mexico | Rosa-Diez [27] | Registry | 2010 | All | 458.0 | 974.9 | |
| United States | USRDS [25] | Registry | 2012 | All | 358.6 | 1968.2 | 1 yr: 79.1 5yr: 41.0 |
—: data not available.
ANZDATA: The Australia and New Zealand Dialysis and Transplant Registry; CORR: Canadian Organ Replacement Register; ERA-EDTA: European Renal Association-European Dialysis and Transplant Association; JSDT: Japanese Society for Dialysis Therapy; LADTR: Latin American Dialysis and Transplant Registry; UKRR: UK Renal Registry; USRDS: United States Renal Data System.
aIncidence at day 91.
bRegional estimate used as proxy for national estimate.
cSurvival estimate is a combined multination estimate from ERA-EDTA; survival from day 91 forward.